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Background: The commonest symptom of peripheral arterial disease
(PAD) is intermittent claudication (IC). This is associated with an in-
creased risk of myocardial infarction, stroke and cardiovascular mor-
tality. Often patients consult general practitioners (GPs) within
primary healthcare sectors. These patients are often referred to the
vascular surgeon for specialist assessment and possible revascularisa-
tion. Misdiagnosis of IC at the primary visit may lead to inappropriate
referral and delayed treatment.
The aim of this study was to determine what proportion of patients
referred for intermittent claudication by GPs in Malta for specialist
vascular assessment actually have vascular disease.
Methods: A cross-sectional observational study was conducted,
where all patients referred to a vascular clinic in a local hospital be-
tween July 2016 and May 2017, due to IC were invited to participate.
Individuals who gave informed consent to participate were assessed
for PAD by hemodynamic analysis including Doppler waveforms,
ankle-brachial pressure index (ABPI), absolute toe pressures and toe-
brachial pressure index (TBPI). A full medical history including
medications taken to assess current risk factor control and associated
participant demographics were noted.
Results: A total of 107 participants were recruited. Fifty-five partici-
pants (51.4%) had a confirmed diagnosis of PAD with abnormal
Doppler waveforms, sub-optimal ABPI and /or absolute toe pressures
and TBPIs. Forty-nine participants (45.8%) had been misdiagnosed,
since they presented with triphasic waveforms and normal ankle and
toe pressures, indicating no significant vascular impairment. Two par-
ticipants had possible mixed aetiology of symptoms with marginally
abnormal hemodynamics and also spinal stenosis. Ten participants
(9.3%) were found to have a systolic blood pressure >160mmHg and
were referred to the GP since they were not taking antihypertensive
therapy. Eighteen (11.5%) participants were referred back to their GP
for risk factor management such as antiplatelet and statins after
diagnosis of PAD was confirmed.
Discussion: Results demonstrate that the diagnosis of PAD cannot be
based solely on clinical symptoms of IC but requires further
hemodynamic analysis prior to referral to the vascular surgeon.
Differential diagnosis from other conditions which may mimic IC,
such as spinal stenosis, is necessary to improve the efficacy of refer-
rals. Inappropriate referrals lead to unnecessary clinical load on a
relatively small department resulting in delayed routine new appoint-
ments with the vascular surgeon.
Doppler waveform analysis, ABPI and TBPIs are essential tests per-
formed by podiatrists as part of the investigation of symptoms of IC.
Use of such haemodynamic testing prior to referral to vascular© The Author(s). 2018 Open Access This artic
International License (http://creativecommons
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the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zesurgery ensures that patients are only referred where haemodynamic
abnormalities are detected as well as identifies those patients with
more severe disease, ensuring appropriate prioritisation of cases.
Furthermore, immediate referral for appropriate risk factor control in
patients with confirmed PAD can be implemented and can lead to a
reduction in major cardiovascular events. Additionally, effective refer-
ral pathways can also be implemented in those patients who present
with symptoms similar to IC due to alternative diagnosis. In patients
with IC, haemodynamic analysis at primary care level is recom-
mended in order to ensure appropriate and efficient patient referral
and decrease the risk of morbidity.
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Background: Moral complexities exist in every day health care prac-
tice creating conflicting responsibilities in providing care. Health care
ethics (HCE) enable an applied practical linkage of theory and prac-
tice to create professional behaviour that focuses on service user
benefit.
This presentation summarises a PhD thesis which was an exploration
of how physiotherapists and podiatrists embodied health care ethics
in their practice. The findings presented locates health care ethics
pertinent to physiotherapy and podiatry in the context of contem-
porary practice in the UK.
Methods: how the study was performed and statistical tests used
Interpretative Phenomenological Analysis (IPA) as a hermeneutical
approach was utilised in order to explore how HCE informs physio-
therapy and podiatry practice. Whilst always involving interpretation,
this method has the ability to describe the human experience as it is
lived. Using a framework embedded in hermeneutic IPA facilitated
an inquiry that promotes the participant’s own reflections of experi-
ential practice (phenomenology) and then interpreting them (her-
meneutical) in the relevant and wider context.
Purposively sampled individual interviews were carried out (n=21) in
an attempt to interpret the participants’ lifeworld of embodied HCE.
The preliminary findings were taken to one purposively sampled
group interview for discussion which contributed to further
interpretation.
Results: Five themes emerged from the data. The themes indicated
that there is a desire by participants to extol ethical practice, but
acknowledged various limitations in the reality of achieving this. The
participant’s host organisation has a cultural role in contributing to
the individual’s actions and behaviours. The individual’s ethical
compass can be blinded by the need for cognitive consonance and
the utilitarian ethical approach adopted in health care organisations.
The place of empathy has a key role in HCE for clinical reasoning
and decision making which may prevent health care practitioners
(HCPs) from passively following performance guidelines and check-
lists. If empathy and virtue ethics can be taught and utilised by HCPsle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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changes were made. The Creative Commons Public Domain Dedication waiver
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an outcome, rather than a prerequisite, of ethical decision making.
Conclusions: Ethical decision making may be enhanced by reconsi-
dering the education of character virtues including empathy.
Empathy is a basic condition and source of morality. As a central
component of phronesis, empathy may enable understanding of a
service user’s needs and increase motivation for HCPs to act in a car-
ing way, thus making the service user the bearer of an ethical
interaction.
Trial registration: This research was given ethical ratification via the
University of Huddersfield School Research Ethics Panel. There were
further approvals granted from local R&D RECs in NHS Trusts.
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Background: Employment is a key measure of self-worth, granting
independence and social esteem. Non-participation in work is associ-
ated with poorer health, higher rates of consultation in primary care
and higher rates of indebtedness and mortality[1]. Musculoskeletal
(MSK) disorders are one of the two biggest causes of long-term work
absenteeism in the developed world [2]. Inflammatory rheumatic dis-
orders in particular have been shown to be associated with high
levels of work disability such that 20-70% of people with rheumatoid
arthritis have become work disabled within 5-10 years of symptom
onset [3]. A recent study by Cherry et al [4] has demonstrated that
lower limb and foot problems are highly prevalent among people
with SLE. Previous work has also shown that these symptoms are as-
sociated with substantial morbidity and functional impairment; 61%
of people reported that foot pain adversely affected their lives [5-7].
However, to our knowledge, no research to date has specifically in-
vestigated the prevalence of, and relationship between, lower limb
or foot related complications, mobility and work non-participation in
this patient group.
Main aim: The aim of this study was to investigate whether foot and
lower limb related symptoms were associated with work participation
and mobility in people with Systemic Lupus Erythematosus (SLE).
Method: A quantitative, cross-sectional, self-reported survey design
was utilised. People with SLE from 6 UK treatment centres and a na-
tional register were invited to complete a survey about lower limb
and foot health, mobility and work participation. Data collected in-
cluded work status and the prevalence of foot symptoms including
the Manchester Foot Pain Disability index (MFPDI). The focus of the
analyses was to explore potential relationships between foot health,
mobility, sickness absence and work participation.
Results: In total 182 useable surveys were returned; 79 (43%) partici-
pants reported themselves as currently employed, 71 (39%) not in
work for non-health related reasons, and 32 (18%) as retired/long-
term absent from work due to SLE and foot symptoms. Work non-
participation due to SLE/foot symptoms was significantly associated
with difficulty walking (p=0.024), past episodes of foot swelling
(p=0.041), and past episodes of foot ulceration (p=0.018). There was
a significant increase in MFPDI scores amongst those not working
(mean 18.13, 95% CI: 14.85 to 21.41) compared to those remaining in
employment (mean 10.16, 95% CI: 8.11 to 12.21).
Conclusions: 29% of people with SLE eligible to work report them-
selves as being on long-term sick leave or having retired earlybecause of SLE and lower limb or foot problems. Foot symptoms
may contribute importantly to work disability in SLE patients. Further
research and clinical time should focus on foot symptoms in SLE
patients.
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Background: Intermittent claudication (IC) is the most common symp-
tom of peripheral arterial disease. Due to the benign prognosis in the
majority of patients, treatment is generally aimed at risk factor control.
However, approximately 15% of patients with IC deteriorate to critical
limb ischaemia (CLI), with increased risk of adverse cardiovascular
events, amputation and death. Understanding the natural history and
the temporal progression of IC, would help in identifying those with in-
creased likelihood of developing CLI. This information is crucial in the
clinical decision whether to offer surgical revascularisation. A structured
review of the current knowledge related to the temporal progression of
symptomatic PAD and the prognosis of IC was conducted.
Methods: The PRISMA checklist for systematic reviews was followed.
A literature search for potentially relevant articles was performed up
to April 2017, in MEDLINE, Cochrane database of systematic reviews,
HyDi and ScienceDirect. HyDi is a search portal provided by the
University of Malta that allows users to perform a single search
through all the library’s resources. No restrictions on publication date
or status were applied. Reference lists of review articles were also
searched for relevant literature. Search terms were identified after
reading publications related to the subject area. Eligible articles pub-
lished in English, needed to report the natural history of IC with a
minimum review period of 12 months, documenting temporal pro-
gression of PAD and identification of prognostic factors. Prospective
cohort studies are most suitable to investigate the natural history of
events however, other methodologies were also considered. Titles
and abstracts were first assessed for relevance and design. Full arti-
cles were retrieved if they were eligible. Methodological quality of
each study was assessed using the Cochrane collaboration checklist.
Data retrieved included trial, details of baseline measurements and
IC diagnostic criteria, trial outcomes reporting temporal progression
and prognostic factors.
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search. Of these, 63 articles were considered relevant on the basis of
title and/or abstract. However, only 7 full-text articles met the selec-
tion criteria (5 Prospective cohort studies, 1 randomised trial and 1
retrospective study), reporting temporal progression and prognostic
factors. Only one study reported yearly haemodynamic decline (ABPI
decline by 0.014), while the rest reported decline at the end of the
trial (up to 12 years) with varied results. This method resulted in most
studies reporting data only of survivors, possibly leading to selective
survival bias with subsequent underestimation of the extent of the
progression of atherosclerosis.
Conclusions: This review highlights existing inconsistencies and a
paucity of scientific evidence related to the temporal progression of
IC. The prognosis and progression of PAD is still not clear in pub-
lished literature. There is a distinct lack of high quality evidence in
the literature to guide appropriate decision making in the context of
revascularisation in IC. More evidence is needed to be able to not
only identify who will deteriorate to CLI, but also to distinguish those
who will deteriorate more rapidly than others and accurately predict
the time interval until development of CLI.
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Background: Foot orthoses (FOs) are frequently used to treat a variety
of foot and lower limb conditions, and are recommended in several na-
tional guidelines. Functional FOs aim to systematically alter abnormal
foot mechanics to alleviate symptoms, and are available in either fully
customised or prefabricated forms. Prefabricated FOs can significantly
reduce manufacturing and clinical costs, but can have comparable
mechanical and clinical effects. Despite this, little is known about which
types of orthoses are used and the only published survey dates from
2001. Our study aimed to describe the types of FOs currently in use
across the United Kingdom (UK), Australia, and New Zealand, and to
determine whether the type of FO prescribed varies between common
conditions.
Methods: This international cross-sectional, online survey hosted on
Bristol Online Surveys explored FO prescribing habits of podiatrists
and was distributed through professional bodies in the UK, Australia,
and New Zealand. Respondents were asked to report which FOs they
prescribed most frequently for patients with 24 common presenta-
tions and conditions.
Results: Two hundred and sixty-four respondents practising in 19 dif-
ferent countries completed the survey; the majority practised in the
UK (124), Australia (79) and New Zealand (32). All podiatrists qualified
between 1968 and 2016 and 147 (56%) were female. Podiatrists
worked in different healthcare sectors and this varied between coun-
tries. For example, 64 (81%) of Australian podiatrists worked solely in
the private sector compared to 14 (44%) of New Zealand podiatrists
and 44 (36%) of UK podiatrists. Forty-two (34%) of UK podiatrists
worked solely in the public sector, compared to 3 (4%) of Australian
podiatrists and 2 (6%) New Zealand podiatrists.
UK podiatrists prescribed more prefabricated FOs (mean 5.5 pairs per
week) than simple FOs (2.7) and customised FOs (2.9). Podiatrists in
New Zealand also prescribed more prefabricated FOs per week on
average (7.7) than simple (1.4) and customised FOs (2.8), whilst those
in Australia prescribed more customised FOs per week (4.5) than sim-
ple FOs (0.8) and prefabricated FOs (1.9). UK respondents were more
likely to prescribe prefabricated FOs than any other type of FO for 21
presentations and conditions, although customised FOs were morelikely to be prescribed for diabetes with peripheral neuropathy,
neurological diseases, and neuromuscular conditions. Podiatrists from
New Zealand were more likely to prescribe prefabricated FOs for
every presentation and condition except tibialis posterior dysfunc-
tion, where customised FOs were more likely. In contrast, customised
FOs were more likely to be prescribed for most presentations and
conditions by podiatrists practising in Australia, although prefabri-
cated FOs were more likely for Morton’s neuroma, forefoot pain, dia-
betes without peripheral neuropathy, gout, connective tissue disease
and falls prevention.
Conclusions: FO prescription habits vary depending on the presenta-
tion or condition that orthotic management is targeting, and the po-
diatrist’s country of practice. Overall, prefabricated FOs were more
frequently prescribed in the UK and New Zealand, where more podi-
atrists undertook public sector work, compared to respondents in
Australia, where most worked solely in private practice and custo-
mised FOs were more common.
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Background: Idiopathic toe walking (ITW) is a diagnosis of exclusion.
It is diagnosed when children over the age of three walk on their tip
toes in the absence of a medical condition known to cause, or be as-
sociated with toe walking. Sensory Processing Disorder is identified
when children and adults are neurologically inundated with sensory
input and unable to process and respond in a way enabling learning
and socially acceptable behaviours [1]. People who have this disorder
may avoid certain encounters or actively seek out experiences to
gain sensory input. There is some evidence that children with ITW
process sensory input differently to their peers [2]. This research
seeks to explore the sensory profiles of children who have attended
podiatry services for ITW.
Method: A retrospective file audit was undertaken of children diag-
nosed with ITW across two podiatry departments between 2011 and
2016. The Sensory profile is 125 questions designed to understand
sensory processing behaviours of children between the ages of 3
and 14. The scoring template converts raw scores, indicating if the
child has a typical performance, more or less probable or definite
difference to a normative population group. Performance scores
were described in quadrants, Sensory Seeking, Low Registration, Sen-
sory Avoiding or Sensory Sensitivity.
Results: There were 60 files sensory profiles extracted. While more
children had presented for ITW, not all podiatrists were trained in
administration and scoring of the Sensory Profile. The mean(SD) age
of children was 5.4 (1.2) years, and there were 29 males, 20 females.
The remaining genders were indeterminable due to extraction
method. Four children had typical performances on all four quad-
rants and six scored a more probable or definite difference on all
four quadrants. The majority scored a more probable or definite dif-
ference on the Sensory Seeking quadrant (n=43, 72%), and Low
Registration quadrant (n=37, 62%). Fewer scored a more probable or
definite difference in the Sensory Avoiding (n=19, 32%) and Sensory
Sensitivity (n=23, 38%). Many children also scored a more probable
or definite different on two or more quadrants (n=36, 60%).
Discussion: Few children displayed a ITW gait and typical sensory
processing behaviours. Many children displayed more than one
cluster of behaviour patterns, particular relating to sensory seeking
behaviours like; touching of people or objects excessively, pursuing
movement, taking excessive risks or lacking awareness of risk. This
potentially points to some children developing a toe walking gait in
response to a need for excessive movement, therefore bouncing
from toe walking gait may be a stimulus. The different sensory pro-
files may impact the success or acceptability of different treatment
options. Future research on sensory gating measurement in this
population should be considered.
Journal of Foot and Ankle Research 2018, 11(Suppl 1):4 Page 4 of 12Conclusion: ITW is a complex gait pattern that commonly presents
to podiatrists. Better understanding the potential reasons children
adopt this gait may be the key to better outcomes. Podiatrists should
consider screening children with ITW for sensory processing difficul-
ties and refer as needed.
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Background: The National Health Service (NHS) is increasingly
stretched driving a need for change. Policymakers require esti-
mates of future demand for foot care to instigate policies but
there is little data available to produce such estimates. Given that
pain is often the driving factor in why, especially in the older
population, patients consult their GPs relative to feet and ankles,
surprisingly there is a corresponding lack of reports on podiatry.
The aim for this investigation was to provide UK wide population
level data and improved understanding of the frequency of foot
and ankle pain recorded in general practice.
Methods: The investigation followed a population-based, retrospect-
ive cohort design. The patient population was drawn from the Clin-
ical Practice Research Datalink (CPRD) between January 2010 and
December 2013, the most recent 4-year period when the study con-
cept was formulated, in order to provide the most up-to-date infor-
mation possible. All the CPRD data were collected prospectively.
Participating GPs data included medical diagnoses, lifestyle informa-
tion, drug prescribing, referrals and tests data covering 11.3 million
patients at present.
Period prevalence and prevalence for recorded foot and ankle pain
were the primary outcome measures. Prevalence for recorded foot
and ankle pain was stratified by age, gender and different sub-
groups of causes for foot and ankle pain. Further stratification by
socio-economic status, lifestyle choices, diabetes and systemic mus-
culoskeletal disease status was performed. An overview of referral
patterns and tests requested by GPs was undertaken to identify key
patterns. Data were analysed descriptively and presented as fre-
quency, range, mean and standard deviation.
Results: For 2010-2013, there was a period prevalence of 7,463
per 100,000 of the population (7.5%) for foot or ankle pain. The
total number of recorded episodes of foot or ankle pain over the
4-year period was 567,095 (mean 1.64, range 1 to 135, SD 1.30),
giving a prevalence of recorded episodes of foot or ankle pain of
3,738 per 100,000 population (multiple same day recordings are
counted once).
The largest groups of patients were female, aged 61-70 years and
had a READ code of ‘foot pain’. Those aged 61-70 place the greatest
burden on GPs in terms of referrals and tests implemented. The most
common specified referrals for foot pain are to orthopaedics and
physiotherapy, with podiatry receiving less than half of those.
Conclusions: This work demonstrates that foot or ankle pain is re-
ported at all age groups. Those aged 61-70 years place the greatest
burden on GPs in terms of recorded foot and ankle pain encounters
and onwards referrals to other health professionals and for tests. This
overall burden presenting to GPs is substantial, yet the majority of
referrals to manage is not to podiatry services.It is clear that work must be accelerated to prioritize an educa-
tion campaign for UK GPs to help them understand the whole
range of foot health management options, beyond those of dia-
betic foot that are offered by podiatrists, and what the referral
pathways to podiatry are.
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Background: The use of ultrasound in podiatry practice encompasses
musculoskeletal ultrasound imaging, vascular hand-held Doppler
ultrasound and therapeutic ultrasound. Currently the practice of son-
ography is not regulated by the HCPC, there is no requirement in the
UK to hold a formal qualification, and the College of Podiatry does
not define ultrasound training and competencies.
Aim and objectives: The primary aim of this study was, for the first
time, to establish the current scope of ultrasound practice amongst
podiatrists in the UK.
The objectives were to:
 Determine the current use of ultrasound within podiatry
practice.
 Determine the current training received by podiatrists.
 Determine the current mentorship received and/or provided by
podiatrists using ultrasound
Methods: A quantitative study utilising a cross-sectional, on-line,
single-event survey was undertaken within the UK. An iterative pilot
phase was included to test and refine the questionnaire.
The survey was launched by the College of Podiatry through national
professional e-newsletters, Specialist Advisory Groups, the Society
professional publication (Podiatry Now) and all Society associated so-
cial media sites.
Results: Completed surveys were received from 284 podiatrists who
routinely used various ultrasound modalities in their practice; 173
(70%) use ultrasound as part of their general practice, 139 (49%) for
musculoskeletal problems, 131 (46%) for vascular/high risk assess-
ment, 3 (1%) for podopaediatrics and 39 (14%) to support their surgi-
cal practice. Almost a quarter of respondents (n=62) worked for
more than one organisation; the majority (n=202, 71%) were
employed by the NHS and/or private sector (n=118, 41%).
Nearly all (93%) participants report using a hand-held vascular
Doppler in their daily practice to assess patients; 216 (82%) to
support decisions regarding treatment options, 102 (39%) to pro-
vide diagnostic reports for other health professionals, and 34
(13%) to guide nerve blocks.
Ultrasound imaging was used by 104 (37%) participants in their prac-
tice primarily to aid clinical decision making (n=81) and guide inter-
ventions including steroid injections (n=67) and nerve blocks (n=39).
Most (93%) stated they use ultrasound imaging to treat their own pa-
tients, while others scan at the request of other podiatrists (n=28) or
health professionals (n=18). Few participants use ultrasound imaging
for research (n=7) or educational purposes (n=2).
Only 32 (11%) participants (n=20 private sector) use therapeutic
ultrasound in their clinical practice to treat patients presenting with
musculoskeletal complaints, namely tendon pathologies.
Few participants (18%) had completed formal post-graduate ultra-
sound courses. However, completion of formal CASE (Consortium for
the Accreditation of Sonographic Education) accredited courses have
increased in popularity over the last five years.
40 (14%) of participants currently receive ultrasound mentorship; the
majority from fellow podiatrists (n=17) or medical colleagues (n=15).
Journal of Foot and Ankle Research 2018, 11(Suppl 1):4 Page 5 of 12Over half (n=127) of participants who do not have ultrasound men-
torship indicated they would like an ultrasound mentor predomin-
antly for the use of ultrasound imaging. 55 (19%) participants report
they currently provide ultrasound mentorship for others.
Conclusions: Understanding the scope of ultrasound practice, the
training undertaken and the requirements for mentorship will underpin
the development of competencies and recommendations defined by
the College of Podiatry to support professional development and en-
sure safe practice.
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Background
In the UK diabetes affects 4.5 million people of whom approximately
2.5% (112,500) have a diabetic foot ulcer (DFU). In 2014-15 NHS
England spent an estimated £972million - £1.13billion, 0.7-0.8% of its
budget on DFU treatment, not taking into account additional social
and public health sector costs. Despite implementation of multidis-
ciplinary care, healing rates for DFUs at 12 weeks with standard ther-
apies are only 7.7-46%. Delays in healing increase the risks of
infection, hospitalisation and amputation. Of those who do not
achieve 50% reduction in ulcer size at 4 weeks, an estimated 30-91%
will not heal by 12 weeks, which is a marker of the need for early ad-
juvant therapies. Several treatment options are available for hard-to-
heal ulcers with few randomised comparisons evaluating them.
Therefore, there is substantial uncertainty surrounding current best
management.
Aims
The MIDFUT trial aims to assess the clinical- and cost-effectiveness of
hydrosurgical debridement alone, or in combination with (i) negative
pressure wound therapy or (ii) decellularised human dermal allograft
or (iii) both, in the treatment of hard-to-heal diabetic foot ulcers.
Methods
MIDFUT is a NIHR HTA-funded, multi-centre, seamless Phase II/III,
open-label, parallel group, multi-arm-multi-stage RCT trial of patients
with DFU. The main eligibility criteria are adult patients with diabetes
and a chronic DFU or surgical debridement wound or open minor
amputation, of at least 1cm2 in area, that shows limited response to
standard care, defined as having <40% reduction in index ulcer area
over a period of at least 4 weeks.
Target recruitment is 660 patients from at least 24 centres over
three years.
Phase II will randomise 324 patients into one of four intervention
arms or treatment as usual (TAU) in a 1:1:1:1:2 allocation. At 4 weeks
post-randomisation the short term outcome of ulcer area reduction
by at least 50%, assessed by clinicians masked to treatment group,
will be used to select at most two of the four intervention arms to
be taken through to Phase III. These intervention arms will have
achieved at least 10% absolute improvement in outcome versus TAU.
If more than two interventions show a sufficient response theninformation on the safety profile and costs of treatments will also be
considered.
There will be a seamless transition to Phase III of the trial. Phase III
will randomise a maximum of 336 patients to (at most) two interven-
tion arms or TAU (1:1:1 allocation). The Phase III primary outcome will
be time to healing of the index ulcer, assessed by clinicians who are
masked to treatment group. Secondary outcomes are: proportion of
DFU healed by 12/20/52 weeks; re-ulceration; infection; revascularisa-
tion; SAEs (e.g. amputation, admission to hospital); QoL (DFU-SF and
EQ-5D-5L) at 4/12/20/52 weeks; health resource utilisation.
HRA approval has been granted and NIHR portfolio adopted. The trial
is currently seeking multi-disciplinary diabetic foot clinics interested
in participation.
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Background: Foot orthoses have historically been issued in the belief
they may positively improve (or correct) skeletal alignment. Despite
practitioners worldwide subscribing to this kinematic mechanism to
explain how foot orthoses work, the published literature is rather in-
consistent in its support for this. However, data does support the
contention that foot orthoses may exert their effects via a kinetic
mechanism (i.e. the modification of the location, magnitude, vector
or temporal patterns of reaction forces at the foot-orthosis interface).
As such great interest should be taken in how the design of a foot
orthosis may influence its ability to generate reaction forces. One fea-
ture of orthosis design which is likely to be key here is the load-
deformation characteristics (stiffness) of the shell.
Methods: The choice of material prescribed, its thickness and also its
geometry will all affect shell stiffness and the subsequent influence
of kinetic parameter changes. In this study we took prefabricated
orthoses with semi-rigid polypropylene shells, 3mm in thickness, EUR
size 42 (KLM Labs, USA) and compared the load-deformation charac-
teristics in the medial longitudinal arch across three different condi-
tions which represented commonly used prescriptions in clinical
practice: [1] unmodified shell [2] shell with addition of 6mm heel
raise [3] shell with addition of 4 degree varus extrinsic rearfoot post.
Results: The devices were fixed to a flat compression plate and verti-
cally loaded from above with an indenter at the highest point of
their medial arch at a rate of 10mm/minute using an INSTRON-5691
(UK) mechanical test machine. The results suggest that the addition
of a 6mm heel raise and a 4 degree varus extrinsic rearfoot varus
post increased the media longitudinal arch stiffness of the devices by
25% and 35% respectively.
Conclusions: Whilst this methodology did not perfectly simulate in-
vivo loading (and care must also be taken at this time to extrapolate
the findings to devices of different materials, thickness and geom-
etries) it may provide some interesting insight into how commonly
used prescriptions are altering the ability of an orthosis to introduce
kinetic changes. Considering one possible clinical application of this
information, it may be reasonable to conclude that if a patient/ath-
lete complains that their devices are too ‘hard’ a first line option
Journal of Foot and Ankle Research 2018, 11(Suppl 1):4 Page 6 of 12could be to remove any extrinsic posting at the rearfoot – this
should decrease the stiffness (increase the compliance) of the device
and improve tolerance and comfort.P02
A proof of concept study for the investigation of the kinetic effect
of variable-hardness insoles on external knee adduction moment
during walking
Simeon Yardely, Lucy Gates, Martin Warner, Catherine Bowen
Faculty of Health Sciences, University of Southampton, Southampton, UK
Journal of Foot and Ankle Research 2018, 11(Suppl 1):P02
Background: There is a clinical agenda for the provision of conserva-
tive interventions that reduce first peak external knee adduction mo-
ment (EKAM1) of individuals with symptomatic medial compartment
knee osteoarthritis. The aim of this preliminary study was to investi-
gate the kinetic effects of a novel variable-hardness insole (VHI) on
EKAM1, to provide proof of concept for this device that justifies fur-
ther investigation in future trials.
Methods: One healthy participant with no history of lower limb
osteoarthritis (female, age 25 years) was recruited to the study. The
effect of VHI on EKAM1 and other kinetic variables during gait, when
worn in a plain outer-soled plimsoll (sole hardness ~Shore A50), was
measured using a 12-camera Vicon motion capture system (Oxford,
UK) with a sampling rate of 100Hz. 3 types of VHI with a lateral-to-
medial hardness ratio range of 1.6-2.6 (hardness Shore A25-65), and
a control insole (hardness Shore A50), were trialled. Visual analogue
scores (VAS) were recorded for participant comfort levels in all shod
conditions.
Results: The VHI with a lateral-to-medial hardness ratio of 2.6 (Insole
3) reduced EKAM1 by 6.30% during walking (0.80±0.03 Nm/kg), as
compared with the control condition (0.85±0.05 Nm/kg). Insole 3
produced 48.09% less medial ground reaction force (GRF), a 11.10%
medial shift in centre of pressure (COP) and 57.40% less knee adduc-
tion angle at EKAM1, as compared with control. Insoles 1 and 2
produced similar kinetic results to control. Insole 3 (94mm) was rated
as more comfortable than the control insole (82mm).
Conclusions: This study provides proof of concept for VHI, and dem-
onstrates its potential as an attractive and comfortable alternative to
existing load modifying devices that reduce EKAM1 during walking.
Kinetic effects for Insole 3 are similar to those of variable stiffness
shoes (VSS), suggesting that a gait adaptation to VHI reduces EKAM1.
Device structure and individual adaptation mechanisms, as well as
lateral-to-medial hardness ratio, influence the effect of VHI on EKAM1.
Further research examining the kinetic effects of VHI in a full-scale RCT,
ultimately in a symptomatic OA population, is warranted.P03
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Background: Foot orthoses (FOs) are recommended in national
guidelines and frequently prescribed for people with both early (< 2
years) and established rheumatoid arthritis (RA). Prefabricated FOs
are cheaper and can exhibit comparable effects to customised
FOs, but published literature varies in its support for their use in
RA. Little is known about what types of FOs clinicians prescribe.
This study aimed to describe FO prescription habits of UK podia-
trists for people with RA.Methods: One Hundred and Twenty-four UK podiatrists completed
an online survey as part of a wider international survey of orthotic
prescription habits hosted on Bristol Online Surveys.
Results: Seventy-five (61%) podiatrists were female. Forty-two (34%) podia-
trists worked solely in the public sector, 44 (36%) worked solely in the pri-
vate/independent sector, and 38 (31%) worked across both. Eighty-eight
(71%) podiatrists treating people with RA prescribed FOs for this condition.
Fifty-seven (46%) podiatrists were most likely to prescribe prefabri-
cated FOs for early RA, whilst 28 (23%) were most likely to prescribe
customised FOs, and 20 (16%) were most likely to prescribe simple
FOs. For established RA, 61 (49%) podiatrists were most likely to pre-
scribe customised FOs, 23 (19%) were most likely to prescribe prefab-
ricated FOs, and 17 (14%) were most likely to prescribe simple FOs.
This pattern was independent of working solely in the public or pri-
vate sector. Fifty-six respondents indicated their preferred prefabri-
cated FO brands for early RA, and 28 respondents for established RA.
Slimflex FOs, (16 podiatrists), were over twice as likely to be pre-
scribed as other brands for early RA. X-Line was the most commonly
prescribed brand for established RA, indicated by 7 podiatrists,
followed by Slimflex (6) and Vasyli (6).
Forty-seven (53%) podiatrists who prescribed FOs for people with RA
indicated that they prescribed customised FOs for people with early
RA at least some of the time, rising to 63 (72%) in established RA.
Foam-impression boxes were used to capture 3D foot shape for
manufacturing custom FOs by 28 (60%) of participants in early RA
and 40 (64%) participants for established RA. The most frequently
specified shell materials for customised FOs in early RA were semi-
flexible (e.g. high density EVA) and semi-rigid (polypropylene), indi-
cated by 17 (36%) respondents in both cases, whilst semi-flexible
materials were most frequently specified for established RA, by 28
(44%) of respondents. Semi-flexible rearfoot posting materials (e.g.
high density EVA) were most frequently specified for both stages of
RA, by 21 (45%) respondents for early RA and 27 (43%) for estab-
lished RA. The most frequently used top covers provided cushioning
(e.g. Poron or polyurethane) for early RA, and cushioning with modifi-
cation or offloading to the forefoot for established RA.
Conclusions: This study describes the most common FO prescriptions
for patients with RA within clinical practice in the UK. Podiatrists were
more likely to prescribe prefabricated FOs in early RA but custom FOs
for people with established disease. The findings help inform decisions
when selecting FOs for future studies and enable clinicians to bench-
mark their practice against national patterns.
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Journal of Foot and Ankle Research 2018, 11(Suppl 1):4 Page 7 of 12Background: Subtalar joint (STJ) disease in patients with rheumatoid
arthritis (RA) is notoriously difficult to assess clinically [1, 2] and
frequently overlooked in favour of assessing the tibiotalar joint.
Pathology in the STJ greatly increases between five and ten years of
disease duration and regularly precedes changes in the tibiotalar
joint [1, 3, 4].
Ultrasound (US) is an accessible, non-invasive, and relatively inexpen-
sive bedside imaging technique, that is repeatable as many times as
required at the time of consultation and is characterised by high pa-
tient acceptability. Although US has been shown to have a higher
sensitivity for detecting inflammation in patients with RA compared
to clinical examination, reliability at the STJ has not been confirmed
in patients with hindfoot problems [5, 6].
Objective: To evaluate the intraobserver and interobserver reliability
of the US assessment of STJ synovitis in patients with RA using
OMERACT consensual definitions.
Methods: Twelve sonographers (10 rheumatologists and two podia-
trists) conducted an US reliability exercise on 10 RA patients with
rearfoot pain. The anteromedial, posteromedial, and posterolateral
STJ was assessed using B-mode and power Doppler (PD) techniques
according to an agreed US protocol and using a 4-grade semiquanti-
tative grading score for synovitis (synovial hypertrophy (SH) and
power Doppler (PD) signal) and a dichotomous score for the
presence of joint effusion (JE). Each patient was randomly assigned
to a sonographer where they were assessed in two rounds, one in
the morning and another in the afternoon. The STJs of both feet
were included in the US assessment. Intraobserver and interobserver
reliability were computed by Cohen and Light kappa. Weighted k co-
efficients with absolute weighting were computed for B-mode and
PD signal. Kappa values of 0-0.20 were considered poor, 0.20-0.40
fair, 0.40-0.60 moderate, 0.60-0.80 good, and 0.80-1 excellent.
Results: Intraobserver reliability
Mean weighted Cohen’s kappa and 95% confidence intervals [CI]
(range) for SH, PD, and JE, was 0.80 (0.62-0.98), 0.61 (0.48-0.73), and
0.52 (0.36-0.67), respectively. Weighted Cohen’s kappa for SH, PD,
and JE in the anteromedial, posteromedial and posterolateral STJ
was -0.04-0.79, 0.42-0.95, and 0.28-0.77; 0.31-1, -0.05-0.65, and -0.2-
0.69; 0.66-1, 0.52-1, and 0.42-0.88, respectively.
Interobserver reliability
Weighted Light kappa (95%CI) for SH was 0.67 (0.58-0.74), 0.46 (0.35-
0.59) for PD, and 0.16 (0.08-0.27) for JE. Weighted Light kappa for SH,
PD, and JE was 0.63 (0.45-0.82), 0.33 (0.19-0.42) and 0.09 (-0.01-0.19)
for the anteromedial; 0.49 (0.27-0.64), 0.35 (0.27-0.4), and 0.04 (-0.06-
0.1) for posteromedial, and 0.82 (0.75-0.89), 0.66 (0.56-0.8), and 0.18
(0.04-0.34) for posterolateral STJ, respectively.
Conclusion: In this multi-observer study of the STJ in patients with
RA, US is a reliable tool for assessing synovitis of the STJ in RA, using
a consensus driven US protocol and agreed scoring system. The most
reliable site is the posterolateral probe position. A reliable imaging
scoring system would be of potential value in clinical practice and re-
search to monitor the effects of drug therapy and mechanical inter-
ventions, such as footwear and orthoses, in patients with RA and
hindfoot pain over time.
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Prevention of pressure ulceration is a key quality indicator through-
out both acute and community settings. Good quality evidence and
national guidelines on how to prevent heel pressure ulcer is limited
(1), An alternative offloading device a soft heel cast has been intro-
duced into Podiatric practise. This qualitative research study aims to
seek the patient perspective of the soft heel cast.
Methods
Patients who had been provided with the soft heel cast were purpos-
ively sampled via a recruitment letter. The aim was to recruit be-
tween six and eight participants. All participants opted in and
provided their written consent to take part in the study. The data
was collected using the exemplary method for an interpretative phe-
nomenological approach (IPA) (2). All interviews were transcribed
and the six stages of analysis appropriate to IPA followed
meticulously.
Results
The analysis identified three inter-related Superordinate themes. It re-
vealed the intimate relationship between the most complex and
powerful theme of pain alongside, 'ergonomics of the optimal off-
loading device' and the 'participants ability to cope'. Five sub themes
were identified and discussed; suffering, comfort, size, identity, and
ulceration duration.
Conclusion
Pain is a complex and subjective phenomenon which cannot be
measured directly rather established by the person experiencing it
(3). Pain is unique and often difficult to describe, as a consequence it
remains poorly understood and inadequately managed. Quality of
life should be considered an equal factor alongside the well known
triad of 'how to heal a wound'. This research clearly highlights how
patients offer suffer in silence.
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Background: Early diagnosis and management of acute charcot neu-
roarthropathy is vital in avoiding the rapid progression towards foot
deformities and complications such as higher risk of ulcerations and
amputation. Clinical pathways currently available on assessment,
diagnosis and management of acute charcot neuroarthropathy are
based on consensus and do not accurately present the evidence. The
aim of this report is to systematically review the current evidence on
the diagnosis, treatment and monitoring for resolution of acute char-
cot neuroarthropathy. Future clinical pathways will be proposed
based on the current evidence reviewed.
Methods: A systematic review of both published and unpublished
scientific papers was undertaken. MEDLINE, EMBASE, CINAHL, AMED
and Cochrane were searched using relevant search terms and key-
words. Unpublished papers were searched on ClinicalTrials.gov. Hand
searching via reference list was also performed. The search results
were then further refined using a systematic approach as described
in Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA). The selected studies were then evaluated for their
methodological quality through critical appraisal tools. A quality
Journal of Foot and Ankle Research 2018, 11(Suppl 1):4 Page 8 of 12assessment of the evidence was performed using the Grading of Rec-
ommendations, Assessment, Development and Evaluation (GRADE)
approach. A narrative synthesis was then conducted.
Results: A total of 24 relevant studies were selected for review. 8
studies were on modalities for diagnosis, 10 on treatment modalities
and 6 on modalities for monitoring of acute charcot neuroarthropa-
thy resolution. Most of the studies were only of fair quality with 1
systematic review, 4 randomised controlled trials, 5 cohort studies, 3
case-control studies and 11 case-series.
The systematic review revealed a paucity of research with much
existing evidence derived from low quality research. Based on the
current evidence reviewed, the ideal modality for diagnosing acute
charcot neuroarthropathy is MRI. Treatment aims of achieving bone
healing, preventing fractures and deformities appear to be from
prompt immobilisation using Total Contact Casting. Treatment with-
drawal based on MRI findings is the most accurate and safe modality
for acute charcot neuroarthropathy. Alternatively, this can be moni-
tored via X-ray if fractures have been established. Based on the find-
ings, a clinical pathway was suggested for the early detection and
optimal management of acute charcotneuroarthropathy.
Conclusion: There is a clear lack of evidence supporting clinical prac-
tice with gaps between evidence and guidelines in the management
of acute charcot neuroarthropathy.The challenge in having a good
quality research in this area are likely due to the low incidence of this
condition, the long healing period and therefore the long-term moni-
toring of outcomes. The proposed clinical pathway for its manage-
ment was based on current best available evidence. Future
implementation will seek to ensure standardised care for diabetic pa-
tients with acute charcot neuroarthropathy, enabling the prevention
of foot deformities.
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Background: In the UK, incidence of viral warts and verrucae in chil-
dren and adolescents is estimated at between 3.9% and 4.9%, with
both genders being equally predisposed to HPV infection (Leiding,
2012). The National Morbidity Survey data (1991-1992) suggests that
almost two million people in England and Wales will see their Gen-
eral Practitioner for the treatment of cutaneous warts each year, at a
cost of an estimated £40 million per annum (Thomas et al, 2006).
95% Silver Nitrate is frequently used in clinical practice; however, has
not been evaluated to determine its’ clinical effectiveness. In
addition, self-administered application of silver nitrate is now com-
mercially available, although awareness of its effectiveness in com-
parison to the clinical application by a health professional is
unknown (Bray, 2007). The aim of this research was to evaluate the
clinical effectiveness of using 95% concentration silver nitrate for the
treatment of verrucae pedis, comparing professional and self-
application methods.
Methods: A Single-centre, two-armed randomized evaluation was
conducted at the University Of Huddersfield podiatry clinic. 113 par-
ticipants (101 analysed) with verruca pedis were recruited voluntarily
to this study. Participants were randomized to either a clinical group,
where silver nitrate was applied by a healthcare professional; or a
home group, where silver nitrate was self-applied.
The main outcome measures were; post treatment pain, controlling
for pre-treatment pain and resolution of the verruca.
An analysis of covariance (ANCOVA) was conducted on the data,
using post-treatment VAS pain as the outcome, controlling for pre-
treatment pain. An ordinal logistic regression was also conducted on
the data, using treatment result as the outcome, with “success” de-
fined to be the reference category.
Results: All participants reported a reduction in pain as a result of
the intervention.A significant reduction in pain was reported in all the participants
who presented with pain prior to treatment (mean pain reduction of
3.98 points on the VAS (SD 2.27)).
The study showed no significant difference between the home and
the clinically applied treatment of verruca pedis, in either of the pri-
mary outcome measures.
There was, however, a substantive difference in resolution between
groups, with 34.0% full resolution and 26.4 % partial resolution in the
clinical treatment group, and 18.8% full resolution and 37.5% partial
resolution in the home treatment group.
Conclusions: Silver nitrate is a safe, cost-effective treatment option
for verruca pedis, with equal success rates when compared between
home and clinical applications. It provides an alternative option for
practitioners which is easy to apply and has no contraindications for
patient suitability.
Trial registration: This clinical evaluation was given ethical ratifica-
tion via the University of Huddersfield School Research Ethics Panel.
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Introduction – There is evidence that a high proportion of the popu-
lation wear incorrectly fitting shoes, and women are more likely to
experience shoe-related foot pain than men [1]. The most common
site of pain is the forefoot [2]. An audit was conducted to gather in-
formation on the percentage of patients seen at an NHS podiatry
community clinic being treated for pathologies caused by narrow-
fitting shoes at the forefoot.
Methods – Two podiatrists independently kept a tally of the number
of patients treated for a pathology where a shoe could be clinically
identified as the cause. Data were collected over a four day period,
by two different podiatrists, at different times of year.
Results – Overall, 10% of all patients presented with midfoot or fore-
foot pathologies caused by a narrow fitting toe-box. In musculoskel-
etal podiatry consultations this increased to 15%, and of those all
were female. In at risk consultations, 8% presented with a pathology
caused by narrow fitting shoes, of these 60% were female (47% of all
podiatry patients are female).
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Background: Idiopathic toe walking (ITW) presents as a gait disorder in
children over three years of age. It is an exclusionary diagnosis, made when
there are no medical conditions known to cause or be associated with that
child walking on their tip toes [1]. ITW can present in up to 5% of children
and in both genders [2]. While management commonly focuses on main-
taining ankle range of motion, no single treatment that has demonstrated
full success in heel-toe gait resolution. Furthermore, there are no consistent
outcome measures used within ITW treatment studies to allow for direct
comparison between treatments. This preliminary research aimed to
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treatment success, when working with children who have ITW.
Method: An expert panel of health professionals, who routinely treat
children with ITW, were recruited for a three round Delphi Panel
using online surveys. The first round of questions collected demo-
graphic data and asked participants open-ended questions about
how they measured parent/child reported treatment success, treat-
ment adherence, gait, pain, ankle range of motion, balance and
strength. Subsequent rounds consisted of statements developed
from initial round responses which participants were required to indi-
cate consensus or agreement. Questions and statements were in-
cluded in the final proforma if >70% of participants indicated
consensus or agreement with the assessment method.
Results: Participants included one Orthopaedic Surgeon, five podia-
trists and four physiotherapists with extensive paediatric experience
and who routinely treated children with ITW. No clinicians work in
the same clinics. All participants completed three rounds. Consensus
was achieved in Round One for four statements, and agreement of
an additional three measures in subsequent rounds. Parent/child re-
ported final items included a parent/child report of time percentage
spent toe walking and quantification of pain, both using an age ap-
propriate visual analogue scale. Final items relating to a clinician ob-
servation or measure included a hybrid gait/strength scale, ankle
range of motion and treatment adherence using a ‘percentage of the
week’ scale.
Discussion: This preliminary research identified measures clinicians
consider in evaluation of ITW treatment outcomes. Clinicians identi-
fied multi-faceted reporting including parent/child recall and physical
examination of; ankle range of motion, gait tasks that rely on heel-
toe gait normalisation and lower limb strength. It is unknown if par-
ents and children also consider these items as important outcome
measures. Future research is underway to determine reliability of the
developed hybrid gait/strength measure and to further understand
parent and child views of what constitute treatment success.
Conclusion: Clinicians believe there is more to ITW treatment success
than just a change in ankle range of motion. Future research will
help develop a standard suite of clinician friendly measures to better
understand the success of the variety of implemented treatments.
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Background: People who have plantar fasciitis (PF) often experience
a lengthy and unpredictable response to conservative treatment. The
rationale for such variable response remains unclear. The aim of this
pilot study was to evaluate the feasibility, potential treatment re-
sponse variance and resource requirement needed to inform a full
longitudinal study of prognostic indicators.
Methods: Ethical approval was gained. A pilot study using a positivis-
tic, quantitative approach of sixteen participants with clinician con-
firmed diagnosis of PF was completed. Three separate recruitment
strategies were established (A, B and C). Participants demographic,
foot biomechanics and plantar fascia tissue characteristics on ultra-
sound (US) were recorded at baseline. The biomechanics of interest
were; Foot posture index (FPI) and ankle dorsiflexion. The US charac-
teristics of interest were; fascial thickness, biconvexity, presence of
calcaneal spur and vascularity. Pain and function were recorded
using 100mm visual analogue scale (VAS) on palpation of the PF in-
sertion (VAS1), first step in the morning (VAS2) and after a period of
activity (VAS3), the PF Pain and Disability Scale (PFPS) and the Footand Ankle Ability Measure (FAAM). Participants received a standard-
ized treatment protocol of footwear advice, stretching and pre-
fabricated foot orthoses in accordance with published guidelines and
local policy. Participants were followed-up at 6 weeks (w) and 12w.
Retention rates, recruitment strategies and treatment compliance
were analyzed to assess the feasibility of the study. Descriptive ana-
lysis explored all variables and the outcome measures were exam-
ined for a clinically meaningful response. Primary and secondary
outcomes were tested using spearman’s rank to assert for correla-
tions to inform a full study.
Results: Fourteen (88%) participants completed baseline, 6w and
12w evaluation. Recruitment strategy A failed to recruit any partici-
pants, whilst B was most effective, recruiting 69% (11/16), followed
by strategy C at 31% (5/16). The average age of participants recruited
was 46.31±7.94 and BMI was 30.76± 5.45. The average FPI and ankle
dorsiflexion was 4.1 ± 3.5, 9.8 ± 3.1, respectively. Fascial thickness
ranged from 4mm – 7.3mm, 56% showed evidence of biconvexity
and none showed any vascularity. At 12w 100% (0/14) of patients
had clinical improvement in VAS1 and 86% (12/14) on VAS2 and
VAS3. Foot function improved in 93% (13/14) of participants and
79% (11/14) of participants had an improvement in reported pain
and disability. Correlational analysis revealed that VAS 2 was the only
outcome measure to have statically significant moderate/strong
positive correlation with all other outcome measures (VAS1 r = 0.770,
p = 0.01; VAS3 r = 0.716 p = 0.004; PFDS r = 0.535 p = 0.049;
FAMM r = 0.703, p = 0.005).
Conclusions: Outcome measures differ strongly in terms of treatment
response. VAS 2 is the most appropriate primary outcome measure
to demonstrate potential maximal treatment response. Minimal US
vascularity was observed and therefore would be a poor characteris-
tic for inclusion. Recruitment via strategy B is the most effective ap-
proach for a study of this kind.
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Background: Metatarsalgia is a common term used to describe pain
in between the metatarsal bones of the forefoot. Forefoot Neuroma
(FFN) is the nerve as it passes between the metatarsal bones and a
cause of metatarsalgia. Current methods of diagnosing FFN are var-
ied and may include interpretations of patient reported symptoms,
clinical observations or tests. However, similar approaches are used
to also diagnose other forefoot pathology such as bursitis, capsulitis
or synovitis, with no clear differentiating factors. Currently, there is
limited evidence to support a specific clinical diagnostic protocol for
FFN. Previous work by the authors has led to the development of an
expert-derived clinical diagnostic protocol for FFN. However the re-
peatability and content validity of this protocol remained unclear.
Aim: To determine the repeatability and content validity of a novel
expert-derived clinical diagnostic protocol for forefoot neuroma.
Method: Ethical approval was obtained (IRAS ref: 14371). A prospective
diagnostic study design was implemented over a 10-month period.
Participants with forefoot pain and no peripheral neuropathy were re-
cruited from a single UK NHS podiatry musculoskeletal service.
The expert-derived clinical diagnostic protocol was used by the same
podiatrist to determine the presence or absence of FFN. A second
podiatrist, with PGCert in foot and ankle ultrasonography, conducted
a standardised forefoot ultrasound examination as the reference
standard to determine the presence or absence of FFN. Both investi-
gators remained blinded to each other’s findings. A sub group of par-
ticipants (n=9) were invited to attend a second appointment to
determine intra-rater repeatability. The data was analysed descrip-
tively to define the population with FFN. The intra-rater repeatability
and content validity of the diagnostic protocol was evaluated using
Journal of Foot and Ankle Research 2018, 11(Suppl 1):4 Page 10 of 12percentage agreement, Kappa analysis and Content Validity Ratio
(CVR) analyses.
Results: Thirty participants were recruited to the study (18=female/
12=male; mean age 58 years, range 37 to 81 years. Of these, 7 partic-
ipants (6=female/1=male) had confirmed FNN via diagnostic muscu-
loskeletal ultrasound and 8 were identified as having FNN from the
clinical assessment protocol. The participant who was diagnosed with
FFN using the diagnostic protocol was diagnosed as forefoot bursitis
with ultrasound. Relative to ultrasound, the diagnostic protocol had a
specificity score of 87.5% and a sensitivity score of 95.6%. The intra-
rater repeatability was k0.58; ‘moderate agreement’. Using the CVR
formula, the most valid components of the diagnostic protocol were:
burning sensations reported by patient (0.87), mulder’s click (0.87)
and paraesthesia (0.73) and the least valid were: no swelling (-0.47),
clicking reported by patient (-0.47) and diastasis (-0.47).
Conclusion: Overall there is evidence to suggest that the diagnostic
protocol for FFN is repeatable and valid. Further analysis and refine-
ment of the diagnostic protocol is required to confirm its clinical util-
ity in practical settings.
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Background: The purpose of this investigation is to establish
whether or not podiatrists (in this case podiatry students) may be ex-
posed to an increased amount or type of microbes in a general clin-
ical environment, depending on their cosmetics usage. Existing
literature describes and explores the microbial contamination of
makeup, the increased exposure of podiatrists to certain microbes
via nail and skin dust, and the possible adhesive nature of cosmetics.
However, makeup is seldom remarked upon in local NHS Trust pol-
icies, and never in an infection control capacity.
Method: An investigation was undertaken across all current podiatry
BSc students, with facial swabs taken from a control group, pre-
patient treatment exposure group and post-patient treatment expos-
ure group. Within these two latter groups were individuals wearing
and not wearing cosmetics.
Results: Microbiological lab analysis identified mixed Staphylococcus
species and some Streptococcus species, which was expected, though
no dermatophytes from the exposure groups which was not expected.
Statistical analysis revealed no link between cosmetics usage and quan-
tity of microbes identified, either between exposure groups or overall
between all makeup wearers and all non-makeup wearers.
Conclusion: Statistical power was lower than is ideal, and so it is sug-
gested that a larger scale investigation would be appropriate to con-
firm or challenge these findings.
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Background: A recent survey of 948 podiatrists across Australia,
United Kingdom and New Zealand found that up to 76% (n=719) re-
ported musculoskeletal pain resulting from their working practices
[1]. Injuries were reported in all parts of the body and the most sig-
nificant injuries were at the low back [1]. The frequency of injuries
was higher than dentists [2] and nurses [3]. No research has quanti-
fied full day lumbar movement patterns in the workplace. This
means, there has been no means of identifying “at risk” behaviors
with objective measures. The aim of this research was to identifylumbar movement patterns of podiatrists during a standard work
day and compare these with other allied health professionals.
Method: All allied health professionals within a metropolitan health
care network were recruited between June and December, 2016. Par-
ticipants wore a movement monitoring system (Vi-Move), enabling
lumbar movement and muscle activity recording in real time. Partici-
pants completed a visual analogue scale (VAS) at the beginning and
end of the work period reporting the intensity of low back pain.
Means (SD) of movement patterns and pre-post VAS analysis was
undertaken. Podiatrists data were extracted and compared to all
other allied health professionals. Pain and frequencies of short term
and sustained postures were explored with parametric and non-
parametric analysis.
Results: Participants included 11 Podiatrists and 82 other allied
health professionals including Physiotherapy, Occupational Thera-
pists, Speech Pathologists and Dietitians. The mean (SD) monitoring
time was 7.7 (0.6) hours. All professions reported a statistically signifi-
cant difference in pain at the beginning and end of the working day
(p=0.04). Podiatrists performed more sustained flexions, extensions,
left and right lateral flexions per hour and to a greater degree than
allied health colleagues, however these differences were not statisti-
cally significant (p>0.05). Podiatrists also spent more time standing
and sitting, and less time walking, than the other professions, again,
the difference was not statistically significant.
Discussion: This is the first study using real time postural monitoring
of health professionals. This study has identified a trend towards po-
diatrists holding more frequent and awkward positions. This may be
a reason podiatrist’s have reported frequent low back pain in past
studies. Those reporting greater low back pain in past studies com-
monly worked in private settings, but this research was undertaken
in hospital and community health services. Future research is needed
with podiatrists in private practices and residential aged care settings
to determine if the setting plays a role in movement patterns.
Additional numbers of podiatry participants are also needed to de-
termine if movement was setting or professional related.
Conclusion: Podiatrists report high levels of low back pain. This is
potentially attributable to the postures held during treatment.
Clinicians need to prioritise their own health to ensure career
longevity and should try to move frequently during treatment,
and move the patient to them rather than hold awkward posi-
tions for longer times.
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Background: Research suggests that toe-brachial index (TBI) can be
significantly more reliable than ankle-brachial index (ABI) when arter-
ial rigidity due to medial artery calcification (MAC) is suspected. The
need to place patients in a supine position to calculate both indices
can be difficult in certain patient groups, including the elderly, those
with respiratory impairment or who are wheelchair-bound. Given a
prior study had validated the use of a hydrostatic pressure formula
to correct ABI measured in a seated to a supine position, a similar in-
vestigation into TBI was considered to be worthwhile for application
to diabetic patients or where MAC is suspected. The findings, if clinic-
ally validated, would offer healthcare professionals an affordable and
reliable tool to identify peripheral arterial disease (PAD) when supine
postures render a traditional approach to TBI infeasible.
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is an association between the values of TBI measured with participants in a
seated and supine position, and to explore the feasibility of predicting TBI
from the blood pressure measurements obtained in a seated position.
Method: The TBI of 35 healthy volunteers was measured in both
seated and supine positions using an automated photoplethysmo-
graphy (PPG) device (BASIC 3.4, Atys Medical). Data analysis included
a Pearson’s correlation test to determine the linear correlation
between TBI in each position. Hydrostatic pressure elimination was
then applied to infer the supine values of toe blood pressure from a
seated position. Regression tests were undertaken to predict supine
TBI. Bland-Altman analysis was conducted to evaluate the agreement
between predicted TBI and measured TBI.
Results: According to the results of Pearson’s correlation test, a posi-
tive and strong linear correlation (r = .598, p < .001) existed between
the value of TBI measured in the two positions. In terms of predicting
supine TBI in regression analysis, the approach of eliminating hydro-
static effect from toe systolic blood pressure (SBP) returned a larger
coefficient of determination (R2 = .467) than the other without
elimination (R2 = .358). With this approach, supine TBI can be ap-
proximated from the inferred supine TBI multiplied by a coefficient
of 0.614 plus 0.309.
Conclusion: The study results and analyses indicated a positive correl-
ation whereby the greater the seated TBI, the higher the corresponding
supine TBI. TBI can be predicted from the seated position with the use
of a hydrostatic pressure formula. However, the predicted values should
be applied with caution due to the limited sample size involved and
potential influence of other parameters; therefore, further investigation
is recommended. A supine position should still be recommended for
measuring the index where possible given that the predicted TBI from
a seated position is not sufficiently agreeable with a supine TBI to be
clinically reliable.
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Background: Peripheral Arterial Disease (PAD) is a long term condi-
tion characterised by atherosclerotic obstruction of the lower extrem-
ity arteries, and is a marker of patients who are at increased risk of
cardiovascular events including myocardial infarction and stroke,
even when it is asymptomatic. The incidence in the over 60s is ap-
proximately 20% and this increases with age and other factors in-
cluding smoking, diabetes and existing coronary arterial disease. In
the lower limb PAD can lead to intermittent claudication, foot ulcer-
ation and critical limb ischaemia; all of which can result in amputa-
tion. As clinicians of the lower limb, podiatrists are able to assess
patients for signs of PAD offering treatment, advice and follow on re-
ferral to secondary care with the vascular surgery team if needed.
The clinical evidence base suggests that this intervention (foot care
and advice on diet and exercise and smoking) is highly effective at
reducing the progression into acute care and can reduce the inci-
dence of amputation by 60%. It is recommended that all commis-
sioners and providers should have a clear pathway for patients
suspected of PAD.
Method: We investigated the clinical and patient centred outcomes
of people with PAD who attended a new podiatry led clinic. All par-
ticipants received an enhanced vascular assessment carried out by a
podiatrist in conjunction with a review of current risk status associ-
ated with this disease (hypertension, high lipids, smoking, low activ-
ity levels and BMI). The clinic was run in conjunction with a dietician
who spoke to each participant about their nutrition and gave advice
on healthy eating. The clinic was delivered from a National Centre
for Sports and Exercise Medicine and every participant was encour-
aged to access these facilities as part of their management plan, if
they agreed. This involved a referral to the exercise team who were
able to devise a tailored, one to one programme for each participant.Conclusions: Primary and secondary outcomes were clinical: presence
of claudication pain, distance walked at 3 and 6 months before onset
of intermittent claudication, blood pressure and lipid monitoring,
weight management, reduced BMI, and the success of any smoking
cessation and activity referral. Quality of life and patient satisfaction
were also assessed. Twenty one patients were recruited and final re-
sults will be available at the end of the study. We will use three case
studies to illustrate preliminary findings and benefits to participants
who have taken part. The case studies illustrate clinical benefits from
this enhanced and joint working approach including increased activity
levels, success of smoking cessation advice, improvement in quality of
life measures and symptoms experienced from PAD.
References:
1. BMJ. Best Practice Guidelines - Peripheral Vascular Disease. BMJ Best
Practice. 2012.
2. National Institute for Health Clinical Excellence. Lower Limb Peripheral
Arterial Disease: diagnosis and management - Clinical Guideline 1472012.
3. All Party Parliamentary Group on Vascular Disease. Tackling Peripheral
Arterial Disease More Effectively: Saving Limbs, Saving Lives2013:




Feet and gait in VitalDanza® – an exploration of embodied
experience
Chris Morriss-Roberts, John Gregory
School of Health Sciences, University of Brighton, Brighton, UK
Journal of Foot and Ankle Research 2018, 11(Suppl 1):P16
Background: Emerging approaches to embodiment theory within
psychotherapy could provide useful insight for physical therapies
with regard to the psychological component which is inherent within
healing and self-care behaviours (both physical and mental) (Koch &
Fuchs, 2011, De Jaegher, Di Paolo, & Adolphs, 2016).
Method: Interpretative Phenomenological Analysis (IPA) is a research
method which can enrich our understanding of human related
factors which play a key role in experience, particularly when applied
to phenomena which have greater life impact (Smith, Flowers &
Larkin, 2009).
The study aimed to investigate the lived experiences of VitalDanza®
with focus on the significance of feet and gait. A voluntary sample of
7 participants who had at least one year experience of VitalDanza®
were recruited. Ethical approval was gained from a UK based Univer-
sity Ethics and Research Governance Panel. Each participant took part
in a semi-structured interview where reflections around feelings,
emotions and sensations involved in and in response to VitalDanza®
were explored.
Results: The IPA approach was used to analyse the interview data
and the 2 superordinate themes which were drawn out were: a) per-
ceived feeling of vitality or intense 'aliveness'; and b) an urge for self-
expression through physical gestures and affectionate touch. 6 sub-
ordinate themes were also drawn out of the data.
The results indicated that participants noted the combination of move-
ment, music and conscious and affectionate interpersonal encounters
being physically and psychologically therapeutic and supporting them
in their personal development and in adjustment to life.
These results can be interpreted through the theory of human agen-
tic capability described by Bandura (2006) and neuroplasticity de-
scribed by Kandel (1998). From a podiatric perspective, the data has
relevance within the theory of podolinguistics. Data analysis points
to the activity and the barefoot state in which it is completed having
a bearing on the psychological and social aspects of movement and
dance steps, and additionally the uniqueness of the functional nature
of the feet in permitting bipedal movement whilst they also have an
erogenous potential (Rossi, 1977, Morriss-Roberts 2013).
Conclusions: VitalDanza® technique is an emerging movement based
technique with therapeutic potential, and can be considered as an
outlet for creative expression, improving social connection and sup-
porting physical and mental health (Martello, 2014).
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Background: The majority of non-traumatic amputations are most
often caused by PAD, followed by diabetes or a combination of both.
People with diabetes are 6 times more likely to have an amputation
than those without (up to 20/day in the UK) with both high monet-ary and human costs. The increased risk for cardiovascular morbidity,
such as myocardial infarction and stroke, and increased risk for mor-
tality is observed in both symptomatic and asymptomatic patients. A
diagnosis of PAD presents the opportunity to initiate secondary pre-
vention by instituting atherosclerosis risk factor modification.This
study aimed to explore the feasibility of combining foot and eye
screening within one appointment. It also aimed to evidence the
prevalence of asymptomatic PAD, uptake of the additional screening
and whether the patient experience welcomed a combined service
in the future.
Method: Potential participants were recruited whilst attending their
retinopathy screening appointments 1 day a week over an 8 week
period. Those consenting had a lower limb arterial assessment using
an automated device measuring ABI and pulse volume negating the
need to rest the patient, and plantar light touch sensation checked,
during the waiting time required for pupil dilation to occur prior to
retinal screening.
Results: Three hundred sixty participants were invited to take part.
89% (n=321) accepted the PAD screening and met the inclusion
criteria. 12% (n=38) were found to have neuropathy; 24.6% (n=79) to
have previously undiagnosed asymptomatic PAD with a 100% posi-
tive patient experience.
Conclusions: The combined screening was well-received and preva-
lence of undiagnosed asymptomatic PAD in this study would indi-
cate targeted screening could allow earlier identification and
intervention of potentially treatable limb and life threatening disease.
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